Amryt Pharma
Company

Amryt Pharma

Biotechnology Research Ie 108 employees
Employees
108
Contacts
3
Emails
3

Amryt Pharma Overview

Headquarters
Ie
Industry
Biotechnology Research
Employees
108
Founded
2015
Funding
125.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Amryt Pharma

Amryt Pharma was acquired by Chiesi Farmaceutici S.p.A. (“Chiesi”) April 12, 2023. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt Pharma's online communities are open to the public. Anything posted to our social networks may be seen and read by everyone. We cannot be responsible for views expressed other than our own. By posting on Amryt Pharma's social media pages, you grant us the right to use or reproduce your content. We welcome questions and commentary, including constructive feedback and differing opinions, but please remember to be both relevant and respectful with what you post. We do not tolerate harassment, abuse, or threats to others. We reserve the right to remove any posts that don’t adhere to our guidelines and to block anyone who violates them repeatedly. Learn more about our community guidelines here: https://amrytpharma.com/social-media-guidelines/

Amryt Pharma Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage

Amryt Pharma Org Chart

Sample employees and titles
Name Title Contact
Munoz Alain Chairman of the Board at Acticor Biotech
Email
Richard Jones New Role at New
View
Ken A.
Email
Atilla Tutuncim, Md General Manager at Amryt Pharma Tr
Email

Employees by Management Level

Individual contributor 2 profiles
Manager 1 profile

Compare Similar Companies to Amryt Pharma